We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RKLB icon
1276
Rocket Lab
RKLB
$35.7B
$293K ﹤0.01%
4,199
-72
-2% -$5.18K
2026 Q2
1 quarter
CPRT icon
1277
Copart
CPRT
$29.1B
$292K ﹤0.01%
10,707
+1,289
+14% +$38.6K
2026 Q1
2 quarters
JETS icon
1278
US Global Jets ETF
JETS
$882M
$292K ﹤0.01%
+10,342
New +$313K
2026 Q3
0 quarters
TOL icon
1279
Toll Brothers
TOL
$13.4B
$287K ﹤0.01%
+2,133
New +$310K
2026 Q3
0 quarters
OSS icon
1280
One Stop Systems
OSS
$111M
$287K ﹤0.01%
32,900
+20,329
+162% +$237K
2026 Q2
1 quarter
PATH icon
1281
UiPath
PATH
$6.11B
$285K ﹤0.01%
+22,226
New +$309K
2026 Q3
0 quarters
IDXX icon
1282
Idexx Laboratories
IDXX
$55B
$285K ﹤0.01%
545
-4,507
-89% -$2.47M
2026 Q2
1 quarter
TENX icon
1283
Tenax Therapeutics
TENX
$65.1M
$284K ﹤0.01%
+150,489
New +$1.13M
2026 Q3
0 quarters
FND icon
1284
Floor & Decor
FND
$5.01B
$284K ﹤0.01%
+6,201
New +$332K
2026 Q3
0 quarters
TFC icon
1285
Truist Financial
TFC
$57.2B
$279K ﹤0.01%
6,030
-3,193
-35% -$162K
2026 Q2
1 quarter
STM icon
1286
STMicroelectronics
STM
$40.1B
$279K ﹤0.01%
5,230
-325,054
-98% -$18M
2026 Q2
1 quarter
BR icon
1287
Broadridge
BR
$20.9B
$278K ﹤0.01%
1,728
-4,290
-71% -$701K
2026 Q2
1 quarter
OVV icon
1288
CALL
Ovintiv
OVV
$16.6B
$278K ﹤0.01%
4,800
-95,900
-95% -$5.87M
2026 Q1
2 quarters
OVV icon
1289
PUT
Ovintiv
OVV
$16.6B
$278K ﹤0.01%
4,800
– –
2026 Q2
1 quarter
CRSP icon
1290
CRISPR Therapeutics
CRSP
$3.9B
$277K ﹤0.01%
5,000
– –
2025 Q4
3 quarters
TPR icon
1291
Tapestry
TPR
$25.2B
$276K ﹤0.01%
2,399
+249
+12% +$33.3K
2026 Q2
1 quarter
LVS icon
1292
Las Vegas Sands
LVS
$24.6B
$273K ﹤0.01%
7,227
+1,689
+30% +$75.3K
2026 Q2
1 quarter
REPL icon
1293
Replimune Group
REPL
$1.88B
$273K ﹤0.01%
20,614
-30,085
-59% -$380K
2026 Q2
1 quarter
AOS icon
1294
A.O. Smith
AOS
$8.67B
$271K ﹤0.01%
+4,800
New +$289K
2026 Q3
0 quarters
MKLYR icon
1295
McKinley Acquisition Corp Rights
MKLYR
$270K ﹤0.01%
+1,000,000
New +$245K
2026 Q3
0 quarters
RNA icon
1296
Atrium Therapeutics
RNA
$143M
$269K ﹤0.01%
32,500
– –
2026 Q1
2 quarters
ZIM icon
1297
ZIM Integrated Shipping Services
ZIM
$3.61B
$264K ﹤0.01%
9,015
-121,286
-93% -$3.27M
2026 Q1
2 quarters
STAG icon
1298
STAG Industrial
STAG
$7.07B
$264K ﹤0.01%
+7,375
New +$281K
2026 Q3
0 quarters
COR icon
1299
Cencora
COR
$66.5B
$263K ﹤0.01%
+876
New +$275K
2026 Q3
0 quarters
AFL icon
1300
Aflac
AFL
$62B
$263K ﹤0.01%
+2,353
New +$282K
2026 Q3
0 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.